Management

René Rückert, M.D., M.B.A., Chief Operating Officer

René Rückert, M.D., M.B.A.

Chief Operating Officer

Dr. Rückert joined in 2019 as Chief Operating Officer at Isarna Therapeutics. He is a medical doctor, board-certified in Biochemistry and a trained Immunologist and holds an MBA. He has a background as immunologist and brings to Isarna an extensive experience in ophthalmology drug development including many years as leader and global manager of ophthalmic drug development at big pharma, developing Eylea and Lucentis at Bayer and Novartis and also at small Biotech’s including roles as Clinical VP, CMO and COO.